Tissue damage and senescence provide critical signals for cellular reprogramming in vivo
Open accessThe DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
For cell reprogramming, context matters: Differentiated cells in a culture dish can assume a new identity when manipulated to express four transcription factors. This “reprogramming” process has sparked interest because conceivably it could be harnessed as a therapeutic strategy for tissue regeneration. Mosteiro et al. used a mouse model to study the signals that promote cell reprogramming in vivo. They found that the factors that trigger reprogramming in vitro do the same in vivo; however, they also inflict cell damage. The damaged cells enter a state of senescence and begin secreting certain factors that promote reprogramming, including an inflammatory cytokine called interleukin-6. Thus, in the physiological setting, cell senescence may create a tissue context that favors reprogramming of neighboring cells. Science , this issue p. 10.1126/science.aaf4445
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“IL-6 produced in the SASP appears to be crucial for the generation of induced pluripotent stem cells in this context.”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [184]
In the citing paper
“Senescence induction is necessary for efficient cell reprograming, as SASP factor production promotes reprogramming into induced pluripotent stem cells in a paracrine manner184.”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [184]
In the citing paper
“In these same models, exogenous tissue damage that drives cellular senescence facilitates reprogramming.”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [184]
In the citing paper
“However, expression of these factors in vivo induces senescence and SASP production, which promotes paracrine senescence as well as reprogramming in non-senescent cells in a cell-non-autonomous manner184.”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [184]
In the citing paper
“SASP factors mediate developmental senescence (Mun ˜ oz-Espı ´n et al., 2013; Storer et al., 2013), wound healing (Demaria et al., 2014), and tissue plasticity (Mosteiro et al., 2016) and also contribute to persistent chronic inflammation (known as inflammaging) (Franceschi and Campisi, 2014).”
From Cellular Senescence: Defining a Path Forward (2019) · cites this paper as Mosteiro et al., 2016
8 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
The Sequence Alignment/Map format and SAMtools
Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., Durbin, R., & 1000 Genome Project Data Processing Subgroup (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp352 · Cited by 62,041
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Ultrafast and memory-efficient alignment of short DNA sequences to the human genome.
Langmead, B., Trapnell, C., Pop, M., & Salzberg, S. L. (2009) · Genome Biology · doi:10.1186/gb-2009-10-3-r25 · Cited by 21,849
López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M., & Kroemer, G. (2013) · Cell · doi:10.1016/j.cell.2013.05.039 · Cited by 14,982
Self-citationTrapnell, C., Roberts, A., Goff, L., Pertea, G., Kim, D., Kelley, D. R., Pimentel, H., Salzberg, S. L., Rinn, J. L., & Pachter, L. (2012) · Nature Protocols · doi:10.1038/nprot.2012.016 · Cited by 12,116
Cellular senescence: from physiology to pathology
Muñoz-Espín, D., & Serrano, M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3823 · Cited by 2,818
Self-citationA complex secretory program orchestrated by the inflammasome controls paracrine senescence
Acosta, J. C., Banito, A., Wuestefeld, T., Georgilis, A., Janich, P., Morton, J. P., Athineos, D., Kang, T.-W., Lasitschka, F., Andrulis, M., et al. (2013) · Nature Cell Biology · doi:10.1038/ncb2784 · Cited by 2,278 · cited 1×
“3A), likely reflecting the loss of SASPmediated paracrine senescence (26).”
BackgroundTelomere Shortening and Tumor Formation by Mouse Cells Lacking Telomerase RNA
Blasco, M. A., Lee, H.-W., Hande, M. P., Samper, E., Lansdorp, P. M., DePinho, R. A., & Greider, C. W. (1997) · Cell · doi:10.1016/s0092-8674(01)80006-4 · Cited by 2,108
Self-citationOncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network
Kuilman, T., Michaloglou, C., Vredeveld, L. C. W., Douma, S., van Doorn, R., Desmet, C. J., Aarden, L. A., Mooi, W. J., & Peeper, D. S. (2008) · Cell · doi:10.1016/j.cell.2008.03.039 · Cited by 2,086 · cited 1×
“The reduction of senescence upon anti– IL-6 is consistent with the known paracrine role of IL-6 in senescence (15).”
BackgroundTumor spectrum analysis in p53-mutant mice
Jacks, T., Remington, L., Williams, B. O., Schmitt, E. M., Halachmi, S., Bronson, R. T., & Weinberg, R. A. (1994) · Current Biology · doi:10.1016/s0960-9822(00)00002-6 · Cited by 2,051
Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice
Chang, J., Wang, Y., Shao, L., Laberge, R.-M., Demaria, M., Campisi, J., Janakiraman, K., Sharpless, N. E., Ding, S., Feng, W., et al. (2016) · Nature Medicine · doi:10.1038/nm.4010 · Cited by 1,819
Chemokine signaling via the CXCR2 receptor reinforces senescence
Acosta, J. C., O'Loghlen, A., Banito, A., Guijarro, M. V., Augert, A., Raguz, S., Fumagalli, M., Da Costa, M., Brown, C., Popov, N., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.038 · Cited by 1,801 · cited 1×
“The master transcription factor NFkB plays a critical role in promoting the secretory activity of senescent cells (16, 23, 24).”
BackgroundRole of the INK4a Locus in Tumor Suppression and Cell Mortality
Serrano, M., Lee, H.-W., Chin, L., Cordon-Cardo, C., Beach, D., & DePinho, R. A. (1996) · Cell · doi:10.1016/s0092-8674(00)81079-x · Cited by 1,585
Self-citationInk4a/Arf expression is a biomarker of aging
Krishnamurthy, J., Torrice, C., Ramsey, M. R., Kovalev, G. I., Al-Regaiey, K., Su, L., & Sharpless, N. E. (2004) · Journal of Clinical Investigation · doi:10.1172/jci22475 · Cited by 1,486
Inflammatory networks during cellular senescence: causes and consequences.
Freund, A., Orjalo, A. V., Desprez, P.-Y., & Campisi, J. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.03.003 · Cited by 1,354
Suppression of induced pluripotent stem cell generation by the p53–p21 pathway
Hong, H., Takahashi, K., Ichisaka, T., Aoi, T., Kanagawa, O., Nakagawa, M., Okita, K., & Yamanaka, S. (2009) · Nature · doi:10.1038/nature08235 · Cited by 1,301
Zhu, Y., Tchkonia, T., Fuhrmann‐Stroissnigg, H., Dai, H. M., Ling, Y. Y., Stout, M. B., Pirtskhalava, T., Giorgadze, N., Johnson, K. O., Giles, C. B., et al. (2016) · Aging Cell · doi:10.1111/acel.12445 · Cited by 1,148 · cited 1×
“Treatment of i4F mice with the Bcl-2/Bcl-xL/ Bcl-w–inhibitor navitoclax, also known as ABT263 (Active Biochem, #A-100) (19, 20), was performed by daily oral gavage for 7 days at 25 mg/kg, dissolved in 15% DMSO/PEG400.”
MethodLinking the p53 tumour suppressor pathway to somatic cell reprogramming
Kawamura, T., Suzuki, J., Wang, Y. V., Menendez, S., Morera, L. B., Raya, A., Wahl, G. M., & Belmonte, J. C. I. (2009) · Nature · doi:10.1038/nature08311 · Cited by 1,115
The promise of induced pluripotent stem cells in research and therapy
Robinton, D. A., & Daley, G. Q. (2012) · Nature · doi:10.1038/nature10761 · Cited by 1,111
Chien, Y., Scuoppo, C., Wang, X., Fang, X., Balgley, B., Bolden, J. E., Premsrirut, P., Luo, W., Chicas, A., Lee, C. S., et al. (2011) · Genes & Development · doi:10.1101/gad.17276711 · Cited by 1,046
Freund, A., Patil, C. K., & Campisi, J. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.69 · Cited by 1,039 · cited 1×
“The master transcription factor NFkB plays a critical role in promoting the secretory activity of senescent cells (16, 23, 24).”
BackgroundDirected elimination of senescent cells by inhibition of BCL-W and BCL-XL
Yosef, R., Pilpel, N., Tokarsky-Amiel, R., Biran, A., Ovadya, Y., Cohen, S., Vadai, E., Dassa, L., Shahar, E., Condiotti, R., et al. (2016) · Nature Communications · doi:10.1038/ncomms11190 · Cited by 1,032
A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity
Marión, R. M., Strati, K., Li, H., Murga, M., Blanco, R., Ortega, S., Fernandez-Capetillo, O., Serrano, M., & Blasco, M. A. (2009) · Nature · doi:10.1038/nature08287 · Cited by 1,028 · cited 1×
“It is well established that Ink4a/Arf, DNA damage, and short telomeres are intrinsic barriers for in vitro reprogramming and, accordingly, in vitro reprogramming efficiency decreases in aged cells (7, 8, 36).”
BackgroundSelf-citationThe Ink4/Arf locus is a barrier for iPS cell reprogramming
Li, H., Collado, M., Villasante, A., Strati, K., Ortega, S., Cañamero, M., Blasco, M. A., & Serrano, M. (2009) · Nature · doi:10.1038/nature08290 · Cited by 968
Self-citationCellular senescence and its effector programs
Salama, R., Sadaie, M., Hoare, M., & Narita, M. (2014) · Genes & Development · doi:10.1101/gad.235184.113 · Cited by 855
Immortalization eliminates a roadblock during cellular reprogramming into iPS cells
Utikal, J., Polo, J. M., Stadtfeld, M., Maherali, N., Kulalert, W., Walsh, R. M., Khalil, A., Rheinwald, J. G., & Hochedlinger, K. (2009) · Nature · doi:10.1038/nature08285 · Cited by 836
Senescence impairs successful reprogramming to pluripotent stem cells
Banito, A., Rashid, S. T., Acosta, J. C., Li, S., Pereira, C. F., Geti, I., Pinho, S., Silva, J. C., Azuara, V., Walsh, M., et al. (2009) · Genes & Development · doi:10.1101/gad.1811609 · Cited by 642
Reprogramming in vivo produces teratomas and iPS cells with totipotency features
Abad, M., Mosteiro, L., Pantoja, C., Cañamero, M., Rayon, T., Ors, I., Graña, O., Megías, D., Domínguez, O., Martínez, D., et al. (2013) · Nature · doi:10.1038/nature12586 · Cited by 547
Self-citationProbing tumor phenotypes using stable and regulated synthetic microRNA precursors
Dickins, R. A., Hemann, M. T., Zilfou, J. T., Simpson, D. R., Ibarra, I., Hannon, G. J., & Lowe, S. W. (2005) · Nature Genetics · doi:10.1038/ng1651 · Cited by 524
Two Supporting Factors Greatly Improve the Efficiency of Human iPSC Generation
Zhao, Y., Yin, X., Qin, H., Zhu, F., Liu, H., Yang, W., Zhang, Q., Xiang, C., Hou, P., Song, Z., et al. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.10.002 · Cited by 468
Ohnishi, K., Semi, K., Yamamoto, T., Shimizu, M., Tanaka, A., Mitsunaga, K., Okita, K., Osafune, K., Arioka, Y., Maeda, T., et al. (2014) · Cell · doi:10.1016/j.cell.2014.01.005 · Cited by 460 · cited 1×
“Recent studies have shown that OSKM overexpression in mice results in cell dedifferentiation in multiple tissue types and reprogramming into iPSCs in vivo (3, 4).”
BackgroundCoppé, J.-P., Patil, C. K., Rodier, F., Sun, Y., Muñoz, D. P., Goldstein, J., Nelson, P. S., Desprez, P.-Y., & Campisi, J. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060301 · Cited by 302 · cited 2×
“We used g-irradiation (20 Gy) to induce a robust senescence response in primary fibroblasts (14).”
BackgroundMethodMolecular pathways: CDK4 inhibitors for cancer therapy
Dickson, M. A. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1551 · Cited by 245
The PIM Family of Serine/Threonine Kinases in Cancer
Narlik‐Grassow, M., Blanco‐Aparicio, C., & Carnero, A. (2014) · Medicinal Research Reviews · doi:10.1002/med.21284 · Cited by 223
Self-citationBleomycin induces cellular senescence in alveolar epithelial cells
Aoshiba, K., Tsuji, T., & Nagai, A. (2003) · European Respiratory Journal · doi:10.1183/09031936.03.00011903 · Cited by 197
The Role of Cell Plasticity in Tissue Repair: Adaptive Cellular Reprogramming
Jessen, K. R., Mirsky, R., & Arthur‐Farraj, P. (2015) · Developmental Cell · doi:10.1016/j.devcel.2015.09.005 · Cited by 155
Pim-1 controls NF-κB signalling by stabilizing RelA/p65
Nihira, K., Ando, Y., Yamaguchi, T., Kagami, Y., Miki, Y., & Yoshida, K. (2009) · Cell Death and Differentiation · doi:10.1038/cdd.2009.174 · Cited by 133
Brady Jennifer, J., Li, M., Suthram, S., Jiang, H., Wong, W. H., & Blau, H. M. (2013) · Nature Cell Biology · doi:10.1038/ncb2835 · Cited by 104
Increased p53 activity does not accelerate telomere‐driven ageing
García‐Cao, I., García‐Cao, M., Tomás‐Loba, A., Martin‐Caballero, J., Flores, J. M., Klatt, P., Blasco, M. A., & Serrano, M. (2006) · The EMBO Reports · doi:10.1038/sj.embor.7400667 · Cited by 102 · cited 1×
“activity that leads to critically short telomere length (33, 34).”
BackgroundSelf-citationSenescence-associated secretory phenotype in a mouse model of bleomycin-induced lung injury
Aoshiba, K., Tsuji, T., Kameyama, S., Itoh, M., Semba, S., Yamaguchi, K., & Nakamura, H. (2013) · Experimental and Toxicologic Pathology · doi:10.1016/j.etp.2013.04.001 · Cited by 100 · cited 1×
“To induce cellular senescence in the lung, we chose the DNA-damaging agent bleomycin, which is a well-known model of lung injury and fibrosis (31, 32).”
MethodThe immunogenicity of cells derived from induced pluripotent stem cells
Fu, X. (2013) · Cellular and Molecular Immunology · doi:10.1038/cmi.2013.60 · Cited by 56
iPSCs: On the Road to Reprogramming Aging
Soria‐Valles, C., & López-Otín, C. (2016) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.05.010 · Cited by 49
Hit to lead evaluation of 1,2,3-triazolo[4,5-b]pyridines as PIM kinase inhibitors
Pastor, J., Oyarzábal, J., Saluste, G., Álvarez, R. M., Rivero‐Buceta, V., Ramos, F., Cendón, E., Blanco‐Aparicio, C., Ajenjo, N., Cebriá, A., et al. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.12.130 · Cited by 45
Self-citationPim-1 Regulates RANKL-Induced Osteoclastogenesis via NF-κB Activation and NFATc1 Induction
Kim, K., Kim, J. H., Youn, B. U., Jin, H. M., & Kim, N. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000885 · Cited by 45
Targeting transcription factor NFκB: comparative analysis of proteasome and IKK inhibitors
Gasparian, A. V., Guryanova, O. A., Chebotaev, D. V., Shishkin, A. A., Yemelyanov, A. Y., & Budunova, I. V. (2009) · Cell Cycle · doi:10.4161/cc.8.10.8415 · Cited by 44
Research works printed but not linked: 1
- 10.1172/jc122475 · doi:10.1172/jc122475
Cited by
Galluzzi, L., Vitale, I., Aaronson, S. A., Abrams, J. M., Adam, D., Agostinis, P., Alnemri, E. S., Altucci, L., Amelio, I., Andrews, D. W., et al. (2018) · Cell Death & Differentiation · doi:10.1038/s41418-017-0012-4 · Cited by 6,680
Hallmarks of aging: An expanding universe
López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M., & Kroemer, G. (2023) · Cell · doi:10.1016/j.cell.2022.11.001 · Cited by 6,549
Self-citationCellular Senescence: Defining a Path Forward
Gorgoulis, V., Adams, P. D., Alimonti, A., Bennett, D. C., Bischof, O., Bishop, C., Campisi, J., Collado, M., Evangelou, K., Ferbeyre, G., et al. (2019) · Cell · doi:10.1016/j.cell.2019.10.005 · Cited by 3,225
Self-citationMacrophages in immunoregulation and therapeutics
Chen, S., Saeed, A. F. U. H., Liu, Q., Jiang, Q., Xu, H., Xiao, G. G., Rao, L., & Duo, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01452-1 · Cited by 2,229
Cellular senescence in ageing: from mechanisms to therapeutic opportunities
Di Micco, R., Krizhanovsky, V., Baker, D., & d’Adda di Fagagna, F. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-00314-w · Cited by 2,277
Metadata
- Authors
- Mosteiro, L., Pantoja, C., Alcazar, N., Marión, R. M., Chondronasiou, D., Rovira, M., Fernandez-Marcos, P. J., Muñoz-Martin, M., Blanco-Aparicio, C., Pastor, J., Gómez-López, G., De Martino, A., Blasco, M. A., Abad, M., & Serrano, M.
- Affiliations
- Spanish National Cancer Research Centre (ES)
- Tumor Suppression Group, Spanish National Cancer Research Centre (CNIO), Madrid E28029, Spain.
- Telomeres and Telomerase Group, CNIO, Madrid E28029, Spain.
- Experimental Therapeutics Programme, CNIO, Madrid E28029, Spain.
- Bioinformatics Unit, CNIO, Madrid E28029, Spain.
- Histopathology Unit, CNIO, Madrid E28029, Spain.
- Corresponding author
- Pantoja, Cristina
- Serrano, Manuel
- Venue
- Science
- Published
- 2016-11-25
- Volume
- 354
- Issue
- 6315
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2553534905
- Cited by
- 589
- References
- 46
- Citations by year
- 2026: 35 · 2025: 43 · 2024: 45 · 2023: 58 · 2022: 74 · 2021: 78 · 2020: 68 · 2019: 63 · 2018: 71 · 2017: 49 · 2016: 5
- FWCI
- 32.56
- Type
- journal article
- Language
- en
- Open access
- green
- zenodo.org
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Zenodo (CERN European Organization for Nuclear Research) (submittedVersion, other-oa)
- Funders
- Spanish Association Against Cancer (AECC)
- European Regional Development Fund
- European Research Council
- European Social Fund
- Botin Foundation
- Banco Santander
- Ramon Areces Foundation
- AXA Foundation
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Keywords
- cellular reprogramming, cellular senescence, tissue damage, OSKM, Oct4, SOX2, KLF4, c-Myc, INK4a/ARF locus, interleukin-6, cytokines, tissue remodeling, tissue repair, aging, pluripotency
- MeSH terms
- Kruppel-Like Factor 4, Aniline Compounds, Animals, Antineoplastic Agents, Gene Expression Regulation, Mice, Inbred C57BL, Sulfonamides, Teratoma, Transcription Factors, Interleukin-6, Proto-Oncogene Proteins c-myc, Cellular Senescence, Cyclin-Dependent Kinase Inhibitor p16, Octamer Transcription Factor-3, Mice, Kruppel-Like Transcription Factors, SOXB1 Transcription Factors, Genetic Loci, Induced Pluripotent Stem Cells, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.